Another BRD4 inhibitor, I‐BET151, also dose‐dependently suppressed the cell viability of both GIST cell lines, although its potency was inferior to that of JQ1 (Figure 4B). The gene discussed is BRD4; the disease is gastrointestinal stromal tumor.